SEC
Fundamental Analysis
4 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PLXSPLEXUS CORP | 58.4 | 100 | 87.1 | 92 | +17.32% | +17.06% | -109.95% | +5,068.37% | -1.33% | 0% | 0 | n/a | 41.62x | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage3 warnings |
| PLXProtalix BioTherapeutics, Inc. | 67.8 | 100 | 100 | 77 | +92.42% | +70.46% | n/a | +158.55% | +7.76% | 0% | 0 | n/a | 9.09x | Gross margin expansion, Operating leverage, Net debt reduction2 warnings |
| MPLXMPLX LP | 27.6 | 53.1 | 53.1 | 71 | +5.93% | n/a | n/a | +4.44% | n/a | 7.64% | 14 | n/a | n/a | Operating leverage, Strong operating leverage |
| MPLXPMPLX LP | 27.6 | 53.1 | 53.1 | 71 | +5.93% | n/a | n/a | +4.44% | n/a | n/a | n/a | n/a | n/a | Operating leverage, Strong operating leverage |
1-4 of 4